Contact us   |  

Treatment of higher risk MDS after hypomethylating agent failure

Treatment of higher risk MDS after hypomethylating agent failure

30/09/2021 17:00

Speakers: Lionel Adès

Target: Health professionals
Subnetworks: Myeloid malignancies
Disease Groups: Myelodysplastic syndrome

Lionel Adès is Professor of hematology at the Hôpital Saint-Louis, and Paris Diderot University, Paris, France. He graduated in Haematology in 2001 and then undertook training in haematology at the Avicenne Hospital and the St Louis Hospital in Paris, before taking up his current position. Prof. Adès has extensive research experience, having worked as a research fellow from 2006-2010 (INSERM, Institut Gustave Roussy) before graduated with a PhD in 2010.

He is conducting several clinical and biological studies in myelodysplastic syndromes and acute leukemia. In these disorders, he has been very active in evaluating novel therapeutics and implementing clinical trials. His research has been published in numerous, well respected journals, including Journal of Clinical Oncology, New England Journal of Medicine and Blood. In addition, Lionel Adès is a member of the American Society of Hematology, the French Group of Myelodysplastic Syndromes and the ALFA Group.

Registration is closed for this webinar